Allogeneic ABCB5-positive Limbal Stem Cells for Treatment of LSCD
Clinical trial NCT03549299 · UNKNOWN
Trial details
- NCT number
- NCT03549299
- Sponsor
- RHEACELL GmbH & Co. KG
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-04
- Primary completion
- 2023-09-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.